Enfusion, Inc. (NYSE:ENFN) Shares Sold by 272 Capital LP

272 Capital LP lowered its position in shares of Enfusion, Inc. (NYSE:ENFNFree Report) by 47.3% in the third quarter, HoldingsChannel.com reports. The firm owned 73,325 shares of the company’s stock after selling 65,855 shares during the quarter. 272 Capital LP’s holdings in Enfusion were worth $696,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. RiverPark Advisors LLC purchased a new position in shares of Enfusion in the 2nd quarter valued at about $68,000. Arizona State Retirement System acquired a new position in Enfusion in the second quarter valued at approximately $86,000. Price T Rowe Associates Inc. MD purchased a new position in Enfusion in the first quarter valued at approximately $102,000. Quadrature Capital Ltd acquired a new stake in Enfusion during the first quarter worth approximately $109,000. Finally, Harbor Capital Advisors Inc. lifted its position in shares of Enfusion by 12.4% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 11,887 shares of the company’s stock worth $113,000 after buying an additional 1,315 shares during the last quarter. Hedge funds and other institutional investors own 81.05% of the company’s stock.

Enfusion Price Performance

NYSE ENFN opened at $9.94 on Friday. The firm’s fifty day moving average price is $9.32 and its 200 day moving average price is $8.89. Enfusion, Inc. has a 12 month low of $7.52 and a 12 month high of $10.45. The company has a market capitalization of $1.28 billion, a price-to-earnings ratio of 248.56, a price-to-earnings-growth ratio of 3.72 and a beta of 0.93.

Enfusion Profile

(Free Report)

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.

Recommended Stories

Want to see what other hedge funds are holding ENFN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enfusion, Inc. (NYSE:ENFNFree Report).

Institutional Ownership by Quarter for Enfusion (NYSE:ENFN)

Receive News & Ratings for Enfusion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enfusion and related companies with MarketBeat.com's FREE daily email newsletter.